The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
KRYS · Healthcare · Narrow moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
PBH · Healthcare · Narrow moat
Wonderful & reasonably priced
| Measure | INFU | KRYS | PBH | DCTH |
|---|---|---|---|---|
| Moat Score (0–100) | 62 (highest) | 62 (highest) | 62 (highest) | 62 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 93 | 100 (highest) | 48 | 70 |
| Pricing power | 66 | — | 94 (highest) | 94 (highest) |
| Returns on capital | 4 | 4 | 13 (highest) | 0 |
| Balance-sheet safety | 64 | 100 (highest) | 62 | 100 (highest) |
| Capital allocation | 83 | 44 | 92 (highest) | 44 |
| 84% above value if growth stopped today | 7831% above value if growth stopped today | 8% below value if growth stopped today (largest discount to value if growth stopped today) | No price data | |
| Market cap | $281M | $9.6B | $2.3B | $514M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2026 | FY2025 |